¶ Brighton Collaboration
.png)
The Brighton Collaboration Foundation, or simply the Brighton Collaboration, is a non-governmental organization based in Basel, Switzerland. It is a program under the Task Force for Global Health which provides administration services and support, including the management of all of the Collaboration’s donations and grants.
¶ History
The Brighton Collaboration originated in 1999 and formed in 2000 to define safety parameters for vaccines, then collect and disseminate it to encourage vaccine uptake worldwide.[1]
In May 2019, Brighton and the Coalition for Epidemic Preparedness Innovations (CEPI) partnered to launch the Safety Platform for Emergency vACcines (SPEAC).[2]
¶ COVID-19
In June 2020, Brighton published a report titled “Priority List of Adverse Events of Special Interest: COVID-19.”[3] It was updated several times up to December 2020. The report was commissioned by CEPI.
¶ Redefining anaphylaxis
The Brighton Collaboration convened an "anaphylaxis working group" in June 2021 consisting of ten members in order to update and revise the definition of anaphylaxis.[4]
¶ Organization
The Brighton Collaboration is a program of the Task Force for Global Health. Currently, the primary funding for the Brighton Collaboration comes from the Coalition for Epidemic Preparedness Innovations (CEPI).
It is a member of the World Health Organization's Vaccine Safety Net, is partnered with the Vaccine Confidence Project,[5] and is associated with HELP Eliminate Pain in Kids & Adults.[6]
¶ Personnel
| Name | Position | Notes |
|---|---|---|
| Ananda Amarasinghe | Anaphylaxis Working Group member[4:1] | WHO Regional Office for the Western Pacific |
| Michael Gold | Anaphylaxis Working Group member | University of Adelaide Medical School |
| Matthew Greenhawt | Anaphylaxis Working Group member | Children's Hospital Colorado, University of Colorado School of Medicine |
| John Kelso | Anaphylaxis Working Group member | Scripps Clinic |
| Sonali Kochhar | Anaphylaxis Working Group member | University of Washington Department of Global Health |
| Bernard Yu-Hor Thong | Anaphylaxis Working Group member | Tan Tock Seng Hospital |
| Karina Top | Anaphylaxis Working Group member | Vaccine Surveillance Reference Group (VSRG), Dalhousie University |
| Paul Turner | Anaphylaxis Working Group member | National Heart and Lung Institute, University of Sydney |
| Margitta Worm | Anaphylaxis Working Group member | Charité – Berlin University Medicine |
¶ Activities
The Brighton Collaboration has provided funding to the World Health Organization.[7]
¶ Publications
Priority List of Adverse Events of Special Interest: COVID-19
¶ External links
¶ Further reading
- April 6, 2023: "Anaphylaxis: Revision of the Brighton collaboration case definition," published in Vaccine
About. Brighton Collaboration. Retrieved April 19, 2022, from https://web.archive.org/web/20220419230552/https://brightoncollaboration.us/about/ ↩︎
Safety Platform for Emergency vACcines (SPEAC). (2019, May 9). Brighton Collaboration. https://web.archive.org/web/20221130041630/https://brightoncollaboration.us/cepi-partners-with-brighton-collaboration-to-support-safety-assessment-of-vaccine-candidates/ ↩︎
Priority List of Adverse Events of Special Interest: COVID-19. (2020, June 10). Brighton Collaboration. http://archive.today/2021.07.15-031510/https://brightoncollaboration.us/priority-list-aesi-covid/ ↩︎
Gold, M. S., Amarasinghe, A., Greenhawt, M., Kelso, J. M., Kochhar, S., Yu-Hor Thong, B., Top, K. A., Turner, P. J., Worm, M., & Law, B. (2022). Anaphylaxis: Revision of the Brighton collaboration case definition. Vaccine, 41(15). https://doi.org/10.1016/j.vaccine.2022.11.027 ↩︎ ↩︎
Partners & Funders. Vaccine Confidence Project. Retrieved April 28, 2022, from https://web.archive.org/web/20220428122506/https://www.vaccineconfidence.org/partners-funders ↩︎
Organizations & Groups (utilizing our work). HELPinKids&Adults. Retrieved February 24, 2024, from https://web.archive.org/web/20240224194827/https://phm.utoronto.ca/helpinkids/publications3.html ↩︎
Voluntary contributions by fund and by contributor, 2017. (2018, April 19). World Health Organization. https://web.archive.org/web/20200605174758/https://www.who.int/about/finances-accountability/funding/A71_INF2-en.pdf ↩︎